Shanghai MicroPort Endovascular MedTech Co., Ltd. announced that it expects to receive CNY 2.5468393 billion in funding
The Company approved the 2022 private placement of A shares in the 9th Meeting of the 2nd Directorate and the 6th Meeting of the 2nd Supervisory Board.
On September 29, 2022, the company announced that the transaction has been approved by the shareholders at 2nd shareholdersâ meeting for 2022.
On December 14, 2022, the company announced that the transaction has been approved by the 13th session of the companyâs 2nd directorate.
On February 2, 2023, the company announced that the Shanghai Stock Exchange has accepted the application for the issuance of stocks and shares to specific objects.
On March 28, 2023, the company announced that the transaction has been approved by the 14th session of the companyâs 2nd directorate.
On May 23, 2023, the company announced that the transaction has been approved by the 16th session of the companyâs 2nd directorate.